PrimeVigilance has designed and implemented integrated safety risk management solutions for companies of various sizes, from single product biotech to international top-10 pharma companies, focusing on approaches that maintain knowledge about drug safety issues, enable the prioritisation of safety issues as important risks, allow for the simple generation of RMP documents (development RMPs, company core RMPs, EU-RMPs, REMs and other types of RMP as required in various parts of the world), and integrate information on the effectiveness of risk minimisation into the risk knowledge base. These approaches have successfully contributed to more transparent decision making about risks and the associated risk management and pharmacovigilance measures.
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)
USA
Croatia
Serbia
Czech Republic
Germany